Bioness, Inc. has announced that its Board of Directors has named Thomas Fogarty as the company’s president and CEO. The appointment was effective as of February 4. Mr. Fogarty succeeded the company’s former president and CEO Yitzhak Zilberman.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Mr. Fogarty holds 25 years of experience in the medical device industry. He has held a variety of senior management positions in public and private companies, such as Johnson & Johnson, Medtronic, Baxter, Edwards Lifesciences and ev3. He has also assisted in the development of global commercialization of over 25 products throughout his career.
Bioness offers innovative Neuromodulation products designed to help certain individuals with central nervous system disorders and diseases such as Stroke, Multiple Sclerosis, Traumatic Brain Injury, Cerebral Palsy and Spinal Cord Injury. These products use electrical stimulation to help people regain mobility, physical independence and productivity. The NESS L300™ Foot Drop System and NESS H200® Hand Rehabilitation System, cleared for use by the Food and Drug Administration and CE-marked for the European Union.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
